San Diego, CA, United States of America

Arnold Satterthwait

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Arnold Satterthwait

Introduction

Arnold Satterthwait is an innovative inventor based in San Diego, California. His work focuses on the regulation of apoptosis, a crucial process in cellular health and disease. With a patent to his name, he has made significant contributions to the field of biomedical research.

Latest Patents

Arnold Satterthwait holds a notable patent for compounds that regulate apoptosis. This patent identifies compounds that modulate the function of anti-apoptotic proteins, particularly Bcl-2 and related family members. The innovative aspect of his work lies in the ability of these compounds to shift the roles of Bcl-2-family member proteins from anti-apoptotic to pro-apoptotic. Furthermore, methods for inducing or preventing apoptosis are explored, along with techniques for discovering molecules that interact with Bcl-2-family members. This research holds potential for developing treatments for proliferative diseases and neurodegenerative disorders.

Career Highlights

Satterthwait currently works at the Burnham Institute, a leading research institution known for its significant advancements in the life sciences. His dedication to his field is evident in his focused research and innovative thinking. His work sets a strong foundation for future studies and potential therapeutic applications.

Collaborations

Throughout his career, Arnold Satterthwait has collaborated with esteemed colleagues, such as Xiao-kun Zhang and Xiuwen Zhu. These partnerships enhance the scope and impact of their research, leading to greater advancements in understanding apoptosis and its regulation.

Conclusion

Arnold Satterthwait is a pioneering inventor whose research into apoptosis regulation has the potential to transform treatment options for various diseases. His work at the Burnham Institute, alongside notable collaborators, underscores his commitment to innovation and improvement in the biomedical field. As he continues to explore this vital area of research, the implications of his findings will undoubtedly resonate through the scientific community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…